Gastric Outlet Obstruction Diagnosis and Management

Primary Malignant Causes

The American Gastroenterological Association suggests that antral carcinoma accounts for approximately 15% of all gastric outlet obstruction cases and represents the most common primary gastric malignancy causing obstruction, presenting with progressive dysphagia, postprandial vomiting, early satiety, and weight loss 1
The National Comprehensive Cancer Network recommends that locally advanced pancreatic cancer, one of the two most frequent causes of malignant gastric outlet obstruction, along with gastric cancer, typically involves the head of pancreas causing extrinsic compression or direct invasion of the duodenum 1
Gastric lymphoma requires tissue diagnosis via endoscopic biopsy to differentiate from adenocarcinoma, with treatment approach differing significantly from adenocarcinoma, making accurate diagnosis critical 3
Duodenal or ampullary neoplasms can cause obstruction at the level of the pylorus or proximal duodenum 1

The American College of Gastroenterology recommends obtaining complete blood count for anemia and leukocytosis, and checking comprehensive metabolic panel for electrolyte abnormalities and renal function 2
The National Institute of Diabetes and Digestive and Kidney Diseases suggests measuring serum bicarbonate, arterial pH, and lactate to exclude intestinal ischemia 2
CT scan with oral and IV contrast is essential to determine location, cause, and extent of obstruction, assess for metastatic disease, and evaluate resectability 2
Upper endoscopy is mandatory to visualize the obstruction, obtain multiple biopsies for histologic diagnosis, and assess feasibility of endoscopic intervention 2, 4

For resectable disease, the National Comprehensive Cancer Network recommends surgical resection as the treatment of choice when curative resection is feasible, with neoadjuvant chemotherapy considered for locally advanced but potentially resectable disease 5
For unresectable/metastatic disease, the American Gastroenterological Association suggests that patients with life expectancy >2 months who are surgically fit should undergo surgical gastrojejunostomy, preferably laparoscopic approach 1, 2, 4
Patients with life expectancy <2 months or poor surgical candidates should receive endoscopic self-expanding metal stent (SEMS) placement, allowing faster resumption of oral intake and shorter hospital stays 1, 2, 4

The American College of Gastroenterology recommends not placing enteral stents in patients with multiple luminal obstructions or severely impaired gastric motility due to limited benefit 6, 2
Consider venting gastrostomy for symptom relief in these patients 6, 2, 4

The National Comprehensive Cancer Network suggests draining ascites before venting gastrostomy placement to reduce infectious complications 3, 2
Severe uncontrolled pain after stent placement requires immediate endoscopic stent removal 3, 2, 4
Poor nutritional status, ascites, and poor functional status predict surgical gastrojejunostomy failure 1